Technology
Health
Biotechnology
DiaMedica Therapeutics Inc. Common Stock
$3.959876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.61 (18.26%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell DMAC and other stocks, options, ETFs, and crypto commission-free!
About
DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It offers DM199 product which focuses on acute ischemic stroke (AIS), and chronic kidney disease (CKD). Read More The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
Employees
7
Headquarters
Minneapolis, Minnesota
Founded
2000
Market Cap
26.18M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
26.19K
High Today
$3.95
Low Today
$3.35
Open Price
$3.36
Volume
130.56K
52 Week High
$13.77
52 Week Low
$2.46
Collections
Technology
Health
Biotechnology
Therapy
Medical
Biopharmaceutical
Pharmaceutical
2018 IPO
Price Paid on Robinhood
14% Higher
Right Now
52 Week Low
$2.46
Average Price Paid
$3.46
52 Week High
$13.77
Earnings
Q4 2018
Estimated
—
Actual
Available Mar 19, After Hours